Rapid Micro Biosystems Statistics
Share Statistics
Rapid Micro Biosystems has 43.83M
shares outstanding. The number of shares has increased by 0.87%
in one year.
| Shares Outstanding | 43.83M |
| Shares Change (YoY) | 0.87% |
| Shares Change (QoQ) | 0.47% |
| Owned by Institutions (%) | 27.36% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 45 |
| FTD / Avg. Volume | 0.01% |
Short Selling Information
The latest short interest is 1.41M, so 3.21% of the outstanding
shares have been sold short.
| Short Interest | 1.41M |
| Short % of Shares Out | 3.21% |
| Short % of Float | 11.32% |
| Short Ratio (days to cover) | 14.29 |
Valuation Ratios
The PE ratio is -0.84 and the forward
PE ratio is -3.39.
Rapid Micro Biosystems's PEG ratio is
0.07.
| PE Ratio | -0.84 |
| Forward PE | -3.39 |
| PS Ratio | 1.4 |
| Forward PS | 2.1 |
| PB Ratio | 0.52 |
| P/FCF Ratio | -0.86 |
| PEG Ratio | 0.07 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Rapid Micro Biosystems.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.61,
with a Debt / Equity ratio of 0.08.
| Current Ratio | 4.61 |
| Quick Ratio | 3.46 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | -0.13 |
| Debt / FCF | -0.14 |
| Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $172,092.02 |
| Profits Per Employee | $-287,662.58 |
| Employee Count | 163 |
| Asset Turnover | 0.29 |
| Inventory Turnover | 1.04 |
Taxes
| Income Tax | 22K |
| Effective Tax Rate | -0.05% |
Stock Price Statistics
The stock price has increased by 276.83% in the
last 52 weeks. The beta is 1.14, so Rapid Micro Biosystems's
price volatility has been higher than the market average.
| Beta | 1.14 |
| 52-Week Price Change | 276.83% |
| 50-Day Moving Average | 2.43 |
| 200-Day Moving Average | 1.57 |
| Relative Strength Index (RSI) | 64.91 |
| Average Volume (20 Days) | 423,939 |
Income Statement
In the last 12 months, Rapid Micro Biosystems had revenue of 28.05M
and earned -46.89M
in profits. Earnings per share was -1.08.
| Revenue | 28.05M |
| Gross Profit | -109K |
| Operating Income | -49.92M |
| Net Income | -46.89M |
| EBITDA | -46.56M |
| EBIT | -49.92M |
| Earnings Per Share (EPS) | -1.08 |
Full Income StatementBalance Sheet
The company has 16.91M in cash and 6.17M in
debt, giving a net cash position of 10.74M.
| Cash & Cash Equivalents | 16.91M |
| Total Debt | 6.17M |
| Net Cash | 10.74M |
| Retained Earnings | -475.27M |
| Total Assets | 98.17M |
| Working Capital | 63.35M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -44.15M
and capital expenditures -1.36M, giving a free cash flow of -45.52M.
| Operating Cash Flow | -44.15M |
| Capital Expenditures | -1.36M |
| Free Cash Flow | -45.52M |
| FCF Per Share | -1.04 |
Full Cash Flow StatementMargins
Gross margin is -0.39%, with operating and profit margins of -177.96% and -167.16%.
| Gross Margin | -0.39% |
| Operating Margin | -177.96% |
| Pretax Margin | -167.08% |
| Profit Margin | -167.16% |
| EBITDA Margin | -165.97% |
| EBIT Margin | -177.96% |
| FCF Margin | -162.27% |
